Advertisement


Executive Director, Health Technology Assessment (HTA) Statistics

B900000 - EXECUTIVE DIRECTOR, HEALTH TECHNOLOGY ASSESSMENT (HTA) STATISTICS

MSD is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. The difference between potential and achievement lies in the spark that fuels innovation and inventiveness; this is the space where MSD has codified its 125-year legacy. MSD's success is backed by ethical integrity, forward momentum, and an inspiring mission to achieve new milestones in global healthcare

MSD is on a quest for cures and is committed to being the world's premier, most research-intensive biopharmaceutical company. Today, we're doubling down on this goal. MRL is a true scientific research facility of tomorrow, and will take MSD's leading discovery capabilities and world-class small molecule and biologics R&D expertise to create breakthrough science that radically changes the way we approach serious diseases.

EXECUTIVE DIRECTOR, HEALTH TECHNOLOGY ASSESSMENT (HTA) STATISTICS

London, ENG, GB
Job #BIO005371

Randomized Clinical Trial (RCT) evidence is an essential component of the benefit argument in Health Technology Assessment (HTA) Dossiers; it is critical to distinguishing the added clinical benefit and health economic utility of MSD products. The HTA Statistics group, within Biostatistics and Research Decision Sciences (BARDS), Global Clinical Development (GCD), is responsible for providing innovative statistical solutions to HTA strategies and problems, and high quality support of HTA Dossiers that align with MRL science and have impact on the market access of MSD medicines.

  • Reporting to the Senior Vice President and Head of BARDS, the incumbent has centralized responsibility and decision making authority for all biostatistics activities in support of HTA Dossiers and submissions. This requires a broad, comprehensive, in-depth knowledge of biostatistics to ensure that sound scientific principles are incorporated into support of HTA strategies and analyses. The incumbent will be the BARDS expert on the biostatistics support of HTA strategies and Dossier submissions.

Primary Activities:

  • Build and maintain a high performing Statistics organization to support all HTA activities related to clinical evidence
  • Promote the novel application of existing statistics methods for HTA submissions (e.g. indirect treatment comparisons, (network) meta analyses, systematic literature reviews and evidence synthesis, adjustments for treatment switching in oncology trials)
  • Foster an effective collaboration with BARDS-HTA Statistics and MRL Center for Observational and Real World Evidence (CORE)
  • Collaborate with BARDS Late Development Statistics (LDS) function to ensure alignment between a  product's regulatory submissions and the product's HTA dossiers/reimbursement submissions
  •  Collaborate with the BARDS Statistical Programming (SP) staff dedicated to HTA to ensure that all deliverables meet analysis requirements, internal standard operating procedures and HTA submission requirements
  •  Proactively interact with HTA agencies worldwide to resolve statistical issues associated with HTA  requests and submissions
  • Stimulate the scientific and technical development of BARDS HTA statisticians relative to HTA methodology.
  • Maintain external contacts that further the objectives and reputation of the BARDS HTA Statistics group's support of HTA submissions (e.g. EUnetHTA).
  • Work closely with MRL-IT to ensure a computing platform that meets the needs for the HTA Statistics organization
  • Leverage BARDS infrastructure and technical functions in support of HTA activities

Qualifications

Education Requirement

  • Master of Science in Statistics required.
  • Doctorate in Statistics is preferred.

Required Skills and Experience:

  • A minimum of 10 years of experience in statistical design and analysis with a working knowledge of computing and data management environments.
  • A minimum of 5 years of management experience with biostatisticians in a major professional environment.
  • Experience in collaborating with clinical scientists.
  • Able to function effectively in a team environment.
  • Excellent oral and written communication skills.
  • Creativity and innovations are expected.

Preferred Skills and Experience:

  • Solid project management skills
  • Ability to work effectively with personnel with different functional backgrounds (e.g. clinical and observational/outcomes research, health economics, market access).
  • Understanding of the HTA environment and the importance of market access activities.

Our employees are the key to our company's success. We demonstrate our commitment to our employees by offering a competitive and valuable rewards program. Our Company's benefits are designed to support the wide range of goals, needs and lifestyles of our employees, and many of the people that matter the most in their lives. If you need an accommodation for the application process please email us at staffingaadar@merck.com.

To be considered for this position, please visit our career site at merck.com/careers, search jobs, create a profile and submit your resume for requisition # BIO005371 to:

https://jobs.merck.com/Merck/job/Upper-Gwynedd-Executive-Director%2C-Health-Technology-Assessment-%28HTA%29-Statistics-PA/512832900/?utm_campaign=BIO005363

Merck is an equal opportunity employer, Minority/Female/Disability/Veteran - proudly embracing diversity in all of its manifestations.

For more information about personal rights under Equal Employment Opportunity, visit:
EEOC Poster
EEOC GINA Supplement